Overview


The Global Radiation Dose Management Market is estimated to value over USD 480 million by 2027 end with a CAGR of over 13.3% during the forecast period 2020 to 2027.
Radiation dose is defined as radiation effect on the skin; it depends on the intensity of radiation, exposure time and sensitivity of the skin. The management of radiation dose components includes information of radiation dose recording software, real-time staff dose monitoring, regulatory compliance and technologies to reduce the dose. There are various techniques like scintigraphies which can deliver low dose radiation with high-quality images of diagnosis, which can calculate and record the dose level and helps in the managing the patient data and sharing with regulatory authorities. Nowadays more patients are investigated through radiation technology to deliver accurate information on disease/disorder.
The growing importance of imaging techniques in the preliminary diagnosis of chronic diseases led to the increasing demand for radiation dose management. Rising demand is further augmented by increasing safety concerns of radiation fuelled the growth of the global radiation dose management market. Further, the rising complexity of imaging techniques led to the development of specific guidelines for better management of radiation dose in primary healthcare settings. Additionally, changing healthcare environment and regulatory scenarios to minimize the radiation complications have boosted the growth of the market. In the recent past, radiation dose management is becoming an integral part of healthcare systems to minimize radiation exposure. The market is expected to witness double growth rate during the forecast period due to increasing adoption radiation dose management techniques in healthcare systems.
North America and Europe radiation dose management markets account major share in the global market due to high penetration among the end-user segments. European radiation dose management market is expected to witness new market players due to rising capital investments among end-user segment. Rising economic conditions in Asia Pacific region is expected to create a potential opportunity space for the market. Latin America and Rest of the world market are expected to witness significant growth rate during the forecast period.
Siemens Healthineers, Philips Healthcare, Ge Healthcare, Qaelum N.V., Fujifilm Holdings Corporation ,Bayer Ag, Sectra Ab, Agfa Healthcare, Canon, Inc., Guerbet, Pacshealth, Llc, Novarad Corporation, Bracco Imaging S.P.A, Infinitt Healthcare, Medsquare Sas, Volpara Solutions Limited, Medic Vision.
Radiation Dose Management Market
By Product and Services
Radiation Dose Management Solutions
Standalone Solutions
Integrated Solutions
Radiation Dose Management Services
Support
Maintenance Services
Implementation
Integration Services
Consulting Services
Education
Training Services
By Modality

    Computed Tomography
    Fluoroscopy
    Interventional Imaging
    Radiography
    Mammography
    Nuclear Medicine
    By Application

      Oncology
      Cardiology
      Orthopedic Applications
      Others
      By End User

        Hospitals
        Small Hospitals
        Large Hospitals
        Ambulatory Care Settings
        Others
        By Region
        Europe
        North America
        APAC
        Latin America
        Rest of World
Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants
Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth
To provide with an exhaustive analysis on global radiation dose management market by product and services, by modality, by application, by end user and region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Radiation Dose Management Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Global Radiation Dose Management Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Radiation Dose Management Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Radiation Dose Management Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Radiation Dose Management Market, By Product and Services Historical Analysis and Forecast 2020-2027 (USD Million)
    •   1. Radiation Dose Management Solutions
         1.1. Standalone Solutions
         1.2. Integrated Solutions
        2. Radiation Dose Management Services
         2.1.Support
      Maintenance Services
         2.2. Implementation
      Integration Services
         2.3. Consulting Services
         2.4. Education
      Training Services
  • 8.   Global Radiation Dose Management Market, By Modality Historical Analysis and Forecast 2020-2027 (USD Million)
    •   1. Computed Tomography
        2. Fluoroscopy
      Interventional Imaging
        3. Radiography
      Mammography
        4. Nuclear Medicine
  • 9.   Global Radiation Dose Management Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
    •   1. Oncology
        2. Cardiology
        3. Orthopedic Applications
        4. Others
  • 10.   Global Radiation Dose Management Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
    •   1. Hospitals
        2. Small Hospitals
        3. Large Hospitals
        4. Ambulatory Care Settings
        5. Others
  • 11.   North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2020-2027
  • 12.   Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2020-2027
  • 13.   Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2020-2027
  • 14.   Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
  • 15.   Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2020-2027
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    •   1. Siemens Healthineers
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Philips Healthcare
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. GE Healthcare
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
          4. QAELUM N.V.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        16.5 . Fujifilm Holdings Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        16.6 . BAYER AG
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. SECTRA AB
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. AGFA HEALTHCARE
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
         9. CANON, INC.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. GUERBET
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. PACSHEALTH, LLC
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. NOVARAD CORPORATION
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
          13. BRACCO IMAGING S.P.A
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. INFINITT HEALTHCARE
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. MEDSQUARE SAS
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. VOLPARA SOLUTIONS LIMITED
         1. Company Overview
         2. Product Portfolio
         3. SWOT Analysis
         4. Financial Overview
         5. Strategic Overview
        17. MEDIC VISION
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients